Literature DB >> 14982838

Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice.

H Clarke Anderson1, Joseph B Sipe, Lovisa Hessle, Rama Dhanyamraju, Elisa Atti, Nancy P Camacho, José Luis Millán, Rama Dhamyamraju.   

Abstract

The presence of skeletal hypomineralization was confirmed in mice lacking the gene for bone alkaline phosphatase, ie, the tissue-non-specific isozyme of alkaline phosphatase (TNAP). In this study, a detailed characterization of the ultrastructural localization, the relative amount and ultrastructural morphology of bone mineral was carried out in tibial growth plates and in subjacent metaphyseal bone of 10-day-old TNAP knockout mice. Alizarin red staining, microcomputerized tomography (micro CT), and FTIR imaging spectroscopy (FT-IRIS) confirmed a significant overall decrease of mineral density in the cartilage and bone matrix of TNAP-deficient mice. Transmission electron microscopy (TEM) showed diminished mineral in growth plate cartilage and in newly formed bone matrix. High resolution TEM indicated that mineral crystals were initiated, as is normal, within matrix vesicles (MVs) of the growth plate and bone of TNAP-deficient mice. However, mineral crystal proliferation and growth was inhibited in the matrix surrounding MVs, as is the case in the hereditary human disease hypophosphatasia. These data suggest that hypomineralization in TNAP-deficient mice results primarily from an inability of initial mineral crystals within MVs to self-nucleate and to proliferate beyond the protective confines of the MV membrane. This failure of the second stage of mineral formation may be caused by an excess of the mineral inhibitor pyrophosphate (PPi) in the extracellular fluid around MVs. In normal circumstances, PPi is hydrolyzed by the TNAP of MVs' outer membrane yielding monophosphate ions (Pi) for incorporation into bone mineral. Thus, with TNAP deficiency a buildup of mineral-inhibiting PPi would be expected at the perimeter of MVs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982838      PMCID: PMC1613274          DOI: 10.1016/s0002-9440(10)63172-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice.

Authors:  C Wennberg; L Hessle; P Lundberg; S Mauro; S Narisawa; U H Lerner; J L Millán
Journal:  J Bone Miner Res       Date:  2000-10       Impact factor: 6.741

2.  Genetic, clinical, biochemical, and pathological features of hypophosphatasia; based on the study of a family.

Authors:  A M BARRETT; D V FAIRWEATHER; R A MCCANCE; A B MORRISON
Journal:  Q J Med       Date:  1956-10

3.  Effect of condensed phosphates on calcification of chick embryo femurs in tissue culture.

Authors:  H Fleisch; F Straumann; R Schenk; S Bisaz; M Allgöwer
Journal:  Am J Physiol       Date:  1966-09

4.  Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia.

Authors:  S Narisawa; N Fröhlander; J L Millán
Journal:  Dev Dyn       Date:  1997-03       Impact factor: 3.780

5.  Calcification of rachitic cartilage to study matrix vesicle function.

Authors:  H C Anderson; S W Sajdera
Journal:  Fed Proc       Date:  1976-02

6.  Analysis of liver/bone/kidney alkaline phosphatase mRNA, DNA, and enzymatic activity in cultured skin fibroblasts from 14 unrelated patients with severe hypophosphatasia.

Authors:  M J Weiss; K Ray; M D Fallon; M P Whyte; K N Fedde; M A Lafferty; R A Mulivor; H Harris
Journal:  Am J Hum Genet       Date:  1989-05       Impact factor: 11.025

7.  Orientation of mineral crystallites and mineral density during skeletal development in mice deficient in tissue nonspecific alkaline phosphatase.

Authors:  W Tesch; T Vandenbos; P Roschgr; N Fratzl-Zelman; K Klaushofer; W Beertsen; P Fratzl
Journal:  J Bone Miner Res       Date:  2003-01       Impact factor: 6.741

8.  Matrix vesicles and calcification of rachitic rat osteoid.

Authors:  T F Johnson; D C Morris; H C Anderson
Journal:  J Exp Pathol       Date:  1989

9.  Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization.

Authors:  Lovisa Hessle; Kristen A Johnson; H Clarke Anderson; Sonoko Narisawa; Adnan Sali; James W Goding; Robert Terkeltaub; José Luis Millan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

10.  Purification and partial characterization of ATP pyrophosphohydrolase from fetal bovine epiphyseal cartilage.

Authors:  H H Hsu
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

View more
  109 in total

1.  Ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) protein regulates osteoblast differentiation.

Authors:  Hwa Kyung Nam; Jin Liu; Yan Li; Andrew Kragor; Nan E Hatch
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Fibroblast growth factor-2 stimulates the proliferation of mesenchyme-derived progenitor cells from aging mouse and human bone.

Authors:  Guomin Ou; Lyndon Charles; Seth Matton; Craig Rodner; Marja Hurley; Liisa Kuhn; Gloria Gronowicz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-07-19       Impact factor: 6.053

Review 3.  FT-IR imaging of native and tissue-engineered bone and cartilage.

Authors:  Adele Boskey; Nancy Pleshko Camacho
Journal:  Biomaterials       Date:  2006-12-18       Impact factor: 12.479

4.  Infrared spectroscopic characterization of mineralized tissues.

Authors:  Adele L Boskey; Richard Mendelsohn
Journal:  Vib Spectrosc       Date:  2005-07-29       Impact factor: 2.507

5.  Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms.

Authors:  Cecilia Halling Linder; Sonoko Narisawa; José Luis Millán; Per Magnusson
Journal:  Bone       Date:  2009-07-22       Impact factor: 4.398

6.  No significant association between genetic polymorphisms in the TNAP gene and ankylosing spondylitis in the Chinese Han population.

Authors:  Ning Cheng; Qing Cai; Meng Fang; Shiwei Duan; Jingan Lin; Jianda Hu; Ruiwen Chen; Shuhan Sun
Journal:  Rheumatol Int       Date:  2008-09-04       Impact factor: 2.631

7.  From design of bio-based biocomposite electrospun scaffolds to osteogenic differentiation of human mesenchymal stromal cells.

Authors:  Julien Ramier; Daniel Grande; Thibault Bouderlique; Olya Stoilova; Nevena Manolova; Iliya Rashkov; Valérie Langlois; Patricia Albanese; Estelle Renard
Journal:  J Mater Sci Mater Med       Date:  2014-03-02       Impact factor: 3.896

8.  Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia.

Authors:  Lothar Seefried; Jasmin Baumann; Sarah Hemsley; Christine Hofmann; Erdmute Kunstmann; Beate Kiese; Yue Huang; Simon Chivers; Marie-Anne Valentin; Babul Borah; Ronenn Roubenoff; Uwe Junker; Franz Jakob
Journal:  J Clin Invest       Date:  2017-04-24       Impact factor: 14.808

9.  Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chick.

Authors:  Vicky E Macrae; Megan G Davey; Lynn McTeir; Sonoko Narisawa; Manisha C Yadav; Jose Luis Millan; Colin Farquharson
Journal:  Bone       Date:  2010-01-04       Impact factor: 4.398

10.  Proteoliposomes harboring alkaline phosphatase and nucleotide pyrophosphatase as matrix vesicle biomimetics.

Authors:  Ana Maria S Simão; Manisha C Yadav; Sonoko Narisawa; Mayte Bolean; Joao Martins Pizauro; Marc F Hoylaerts; Pietro Ciancaglini; José Luis Millán
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.